Report Code : CVMI2412262 | Published Date : March 3, 2025

The global Antimicrobial Resistance (AMR) market was valued at USD 9.4 billion in 2023 and is projected to reach USD 21.6 billion by 2031, growing at a CAGR of 10.9%. Novel drug development, rapid diagnostics, and AI-powered solutions to combat superbugs are transforming the market.

2024 Market Breakthroughs

  • Phage Therapy Commercialization:
    • Adaptive Phage Therapeutics' FDA-approved phage cocktail treats all tested MRSA cases with a success rate of 100%.
    • Locus Biosciences' CRISPR-engineered phages reduce E. coli infections by 99% in trials.
  • AI-Drug Discovery:
    • Exscientia's AI-designed antibiotic (XAI-101) demonstrates ten times the potency against gram-negative bacteria.
    • BenevolentAI's platform identified three novel AMR targets in 2024.
  • Rapid Diagnostics:
    • Cepheid's Xpert® Carba-R detects carbapenem resistance in 45 minutes (vs. 3 days).
    • Oxford Nanopore's handheld sequencer identifies resistance genes in real-time.

Market Drivers

1. Rising Superbug Threats

  • 1.27 million deaths/year directly attributable to AMR (WHO 2024).
  • Carbapenem-resistant infections increased 350% since 2015.

2. Policy & Funding Shifts

  • US PASTEUR Act guarantees USD 3B/year for novel antibiotics through 2030.
  • EU's AMR Action Plan mandates 50% reduction in human antibiotic use by 2025.

3. Diagnostic Advancements

  • FDA's 2024 Breakthrough Device Designation for 5 rapid AMR tests.
  • Reimbursement reforms now pay hospitals for diagnostic-guided therapy.

Competitive Landscape

Company

Market Share

Flagship Product

Strategic Edge

Merck & Co.

25%

Relebactam (β-lactamase inhibitor)

Hospital formulary dominance

Shionogi

20%

Cefiderocol (siderophore antibiotic)

Novel iron-uptake mechanism

Thermo Fisher

15%

AMR Gene Panels

Gold-standard diagnostics

Emerging Disruptors:

  • Nobio: Antimicrobial polymers for medical devices (FDA-cleared in 2024).
  • Day Zero Diagnostics: AI-powered genome sequencing for outbreak tracing.

Market Segmentation

  • By Product:
    • Drugs (60%): Novel antibiotics dominate.
    • Diagnostics (XX%): Fastest-growing segment (18% CAGR).
    • Prevention (XX%): Surface coatings, vaccines.
  • By Pathogen:
    • Gram-Negative (XX%): K. pneumoniae, P. aeruginosa.
    • Gram-Positive (XX%): MRSA, VRE.
  • By Region:
    • North America (XX%): Leading in novel drug development.
    • Europe (XX%): Strongest AMR stewardship policies.
    • Asia-Pacific (XX%): High antibiotic misuse driving resistance.

Recent Developments (2024)

  • May 2024: FDA fast-tracks XAI-101 for XDR A. baumannii.
  • August 2024: EU approves first phage therapy for chronic wounds.




Reasons To Buy

Image



Scope

Image

Key Players

  • Anti-Microbial Resistance Market – Pfizer Inc.
  • Merck & Co. Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Sanofi
  • Novartis AG
  • Bayer AG
  • Eli Lilly and Company
  • AstraZeneca plc
  • Roche Holding AG.

Global Anti-Microbial Resistance Market Report

Global Anti-Microbial Resistance Market Report

  1. 1. Global Anti-Microbial Resistance Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Anti-Microbial Resistance Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Anti-Microbial Resistance Market Research Report - Preface
    1. 2.1 Global Anti-Microbial Resistance Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Pathogen Type
      2. 2.1.2 By Drug Type
      3. 2.1.3 By Application
      4. 2.1.4 By Region
    3. Global Anti-Microbial Resistance Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Pathogen Type, By Drug Type, By Application, By Country
    3. 3.3. Opportunities – By Pathogen Type, By Drug Type, By Application, By Country
    4. 3.4. Trends – By Pathogen Type, By Drug Type, By Application, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Anti-Microbial Resistance Market Research Report – DROTs Impact Analysis
    4. Global Anti-Microbial Resistance Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Anti-Microbial Resistance Market, By Pathogen Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Bacteria
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Viruses
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Fungi
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Anti-Microbial Resistance Market, By Drug Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Antibiotics
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Antifungals
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Antivirals
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Anti-Microbial Resistance Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Hospitals
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Clinics
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Outpatient Settings.
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Anti-Microbial Resistance Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 8.5 Middle East & Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 8.6 Global Anti-Microbial Resistance Market - Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Region, 2024 - 2031
    9. North America Anti-Microbial Resistance Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Pathogen Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Bacteria
      2. 9.1.2 Viruses
      3. 9.1.3 Fungi
      9.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Antibiotics
      2. 9.2.2 Antifungals
      3. 9.2.3 Antivirals
      9.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Hospitals
      2. 9.3.2 Clinics
      3. 9.3.3 Outpatient Settings.
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
      9.5 North America Global Anti-Microbial Resistance Market – Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Country, 2024 - 2031
      9.6 Regional Trends Analysis
      9.7 North America Global Anti-Microbial Resistance Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe  Anti-Microbial Resistance Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Pathogen Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Bacteria
      2. 10.1.2 Viruses
      3. 10.1.3 Fungi
      10.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Antibiotics
      2. 10.2.2 Antifungals
      3. 10.2.3 Antivirals
      10.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Hospitals
      2. 10.3.2 Clinics
      3. 10.3.3 Outpatient Settings.
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Netherlands
      8. 10.4.8 Poland
      9. 10.4.9 Rest of Europe
      10.5 Europe Global Anti-Microbial Resistance Market – Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Country, 2024 - 2031
      10.6 Regional Trends Analysis
      10.7 Europe Global Anti-Microbial Resistance Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Anti-Microbial Resistance Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Pathogen Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Bacteria
      2. 11.1.2 Viruses
      3. 11.1.3 Fungi
      11.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Antibiotics
      2. 11.2.2 Antifungals
      3. 11.2.3 Antivirals
      11.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Hospitals
      2. 11.3.2 Clinics
      3. 11.3.3 Outpatient Settings.
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & NZ
      6. 11.4.6 ASEAN
      7. 11.4.7 Rest of Asia-Pacific
      11.5 Asia-Pacific Global Anti-Microbial Resistance Market – Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Country, 2024 - 2031
      11.6 Regional Trends Analysis
      11.7 Asia-Pacific Global Anti-Microbial Resistance Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Anti-Microbial Resistance Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Pathogen Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Bacteria
      2. 12.1.2 Viruses
      3. 12.1.3 Fungi
      12.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Antibiotics
      2. 12.2.2 Antifungals
      3. 12.2.3 Antivirals
      12.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Hospitals
      2. 12.3.2 Clinics
      3. 12.3.3 Outpatient Settings.
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
      12.5 Latin America Global Anti-Microbial Resistance Market – Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Country, 2024 - 2031
      12.6 Regional Trends Analysis
      12.7 Latin America Global Anti-Microbial Resistance Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East & Africa Anti-Microbial Resistance Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Pathogen Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Bacteria
      2. 13.1.2 Viruses
      3. 13.1.3 Fungi
      13.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Antibiotics
      2. 13.2.2 Antifungals
      3. 13.2.3 Antivirals
      13.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Hospitals
      2. 13.3.2 Clinics
      3. 13.3.3 Outpatient Settings.
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 South Africa
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
      13.5 Middle East & Africa Global Anti-Microbial Resistance Market – Opportunity Analysis Index, By Pathogen Type, By Drug Type, By Application, and Country, 2024 - 2031
      13.6 Regional Trends Analysis
      13.7 Middle East & Africa Global Anti-Microbial Resistance Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
      14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Anti-Microbial Resistance Market – Pfizer Inc.
      2. 14.2.2 Merck & Co. Inc.
      3. 14.2.3 GlaxoSmithKline plc
      4. 14.2.4 Johnson & Johnson
      5. 14.2.5 Sanofi
      6. 14.2.6 Novartis AG
      7. 14.2.7 Bayer AG
      8. 14.2.8 Eli Lilly and Company
      9. 14.2.9 AstraZeneca plc
      10. 14.2.10 Roche Holding AG.
    15. Data Collection Method and Research Approach
    16. Principal Presumptions and Acronyms